Jove
Visualize
Contact Us

Related Experiment Videos

MELD-based liver allocation: who is underserved?

Scott W Biggins1, Kiran Bambha

  • 1Division of Gastroenterology and Hepatology, University of California, San Francisco, CA 94143, USA.

Seminars in Liver Disease
|July 20, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reply: Validation of MELD 3.0 in 2 centers from different continents.

Hepatology communications·2026
Same author

Waitlist mortality in liver transplantation: Understanding metrics, regulatory implications, and clinical management strategies.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2026
Same author

Frailty Increases Hospitalization Rates in an Ambulatory Cohort of Patients With Cirrhosis: The North American Consortium for the Study of End-Stage Liver Disease 3 Prospective Cohort.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2026
Same author

The management of hepatorenal syndrome-acute kidney injury (HRS-AKI): A national survey of hepatology provider practices.

Hepatology communications·2026
Same author

Erratum: Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases.

Hepatology (Baltimore, Md.)·2025
Same author

Salivary microbiome and serum metabolomics add to clinical biomarkers to predict 6-month hospitalizations in a multicenter cirrhosis outpatient cohort.

Hepatology (Baltimore, Md.)·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

The current liver allocation system, based on the Model for End-Stage Liver Disease (MELD) score, effectively prioritizes most patients. However, some individuals with liver disease may not be adequately served by MELD alone.

Area of Science:

  • Transplantation immunology
  • Hepatology
  • Public health policy

Background:

  • Deceased-donor liver allografts are a limited resource crucial for patients awaiting transplantation.
  • Current liver allocation policies prioritize deceased-donor organs based on medical urgency.
  • The Model for End-Stage Liver Disease (MELD) score is the foundation of the current allocation system.

Purpose of the Study:

  • To review the development and implementation of the MELD-based liver allocation system.
  • To identify potential limitations of the MELD system in prioritizing all patients.
  • To explore areas for improvement in liver allograft allocation policies.

Main Methods:

  • Review of the historical development of the MELD score.
  • Analysis of the MELD-based liver allocation system's effectiveness.

Related Experiment Videos

  • Discussion of patient populations potentially underserved by current MELD criteria.

    • Main Results:

    • The MELD system accurately predicts short-term mortality for 83-87% of waitlisted liver transplant candidates.
    • Certain liver disease patients may have survival dependent on factors not captured by MELD parameters.
    • These patients might be underserved by existing MELD-based allocation policies.

    Conclusions:

    • The MELD-based system is largely effective but may not encompass all critically ill liver patients.
    • Continuous refinement of liver allocation policies is necessary to ensure equitable distribution of scarce donor organs.
    • Further research is warranted to address limitations and improve the MELD system for optimal patient prioritization.